2020
DOI: 10.1021/acs.jmedchem.0c00228
|View full text |Cite
|
Sign up to set email alerts
|

Women in Medicinal Chemistry: Ad Maiora!

Abstract: Journal of Medicinal Chemistry is proud to share the release of its first special issue dedicated to "Women in Medicinal Chemistry", jointly published with ACS Medicinal Chemistry Letters.We were overwhelmed at the level of interest following the Call for Papers for this special issue. 1 The number of submissions received was high, far more than we anticipated. We interpret this large response in two ways. First, we believe that the female medicinal chemistry community has an enduring enthusiasm to be more vi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 5 publications
0
4
0
Order By: Relevance
“…It is worth noting that the highest impact journals publishing full papers (JMC) and letters (ACS MCL) have some of the lowest proportions of female corresponding authors from the journals studied; both journals are taking action to support systemic changes. ,, This may reflect the gender balance in higher ranking institutions, which tend to be poorer–as authors from these institutions are on balance more likely to publish in higher impact journals . A further underpinning reason is likely to be the “leaky pipeline” for female medicinal chemists. , …”
Section: Gendermentioning
confidence: 99%
See 1 more Smart Citation
“…It is worth noting that the highest impact journals publishing full papers (JMC) and letters (ACS MCL) have some of the lowest proportions of female corresponding authors from the journals studied; both journals are taking action to support systemic changes. ,, This may reflect the gender balance in higher ranking institutions, which tend to be poorer–as authors from these institutions are on balance more likely to publish in higher impact journals . A further underpinning reason is likely to be the “leaky pipeline” for female medicinal chemists. , …”
Section: Gendermentioning
confidence: 99%
“…In contrast, previous studies have focused on gender balance in science, patents, and chemistry as a whole; the granularity for medicinal chemistry is not reported. The experiences of female chemists and gender balances in some of the subdisciplines in chemistry have been described including computational chemistry, medicinal chemistry, organic chemistry, supramolecular chemistry, and process research . Excellent recommendations and calls to action have been made. , Additionally, preliminary bibliometric studies of chemistry articles focusing on gender by the Royal Society of Chemistry in the United Kingdom (UK) and by Cotton and Seiple have been reported, but we are unaware of detailed data for medicinal chemistry articles as presented here.…”
Section: Introductionmentioning
confidence: 99%
“…As is the case with ACS Pharmacology & Translational Sciences , the main contributors should be identifiable from the author list and differentiated from authors included predominantly for political or managerial reasons. ,, Given the importance of diversity, the nationality and gender of the authors should also be recorded by the journal in a suitably secure form. This may be viewed as controversial, but there is now a substantial literature exploring these topics. …”
Section: Conclusion and The Future: Scientific Publishing Is Changingmentioning
confidence: 99%
“…One third of the recipients of EFMC recognition schemes over the years 2018-2020 have been female, with two out of six awards, including the most prestigious Nauta Award to Prof. Christa Müller (Bonn University) and two out of six Prizes, respectively, while women were completely absent from the lists of awardees and prize winners until quite recently. [7] Similar changes are occurring across other learned societies and institutions, and efforts towards gender equity have been discussed in a number of publications, [71][72][73][74][75][76] Recently they have been the topic of an EFMC-YSN webinar on "Women in Medicinal Chemistry", followed by a round-table discussion. [77] Third, an increasing number of younger scientists are actively becoming involved in shaping the medicinal chemistry community.…”
Section: Current Trends and Future Outlookmentioning
confidence: 99%